Nakornthon Hospital Public Company (NKT) Fair Value & Analysis
Healthcare · TH · Market cap 2.1B THB
Fair value as of: Jun 24, 2026
From 12 valuation models · updated 5 days ago
Share price −2.6% over the past month.
Price vs Fair Value (12 months)
12‑month range 3.75 THB – 4.23 THB · fair‑value band 4.06 THB – 7.54 THB · the 3.82 THB price screens below the 5.80 THB fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Nakornthon Hospital Public Company (NKT) currently trades at 3.82 THB, while our model-based Fair Value estimate is 5.80 THB — implying the stock looks roughly 51.8% undervalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Nakornthon Hospital Public Company generated revenue of 2.0B THB at a net margin of 7.3%. Revenue declined 1.8% year over year. It earns a return on equity of 7.3%. The stock trades on a trailing P/E of 13.9. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Nakornthon Hospital Public Company Limited, together with its subsidiaries, operates a hospital that provides various medical services in Thailand. It offers centers for cancer, spine, orthopedics, rainbow services, pain management care, geriatric care, gastrointestinal and liver, neurology, children health, internal medicine, fertility, heart, wellness, aesthetics and skin, surgery, rehabilitation, eyes, women health, ears, nose, throat, breast, dental, allergy and immunology care, breastfeeding care, hemodialysis, emergency medicine, and medical imaging. The company is also involved in elderly and dependent care center. Nakornthon Hospital Public Company Limited was incorporated in 1993 and is based in Bangkok, Thailand.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Nakornthon Hospital Public Company reported revenue of 2.0B THB in FY2025 versus 1.9B THB in FY2022, a compound +0.8%/yr. Reported net income was 195M THB in FY2025, compounding −15.2%/yr from FY2022.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$97.60 | R$115.75 | +19% |
| Fresenius SE FSNUY | $11.47 | $8.55 | -25% |
| 5225 5225 | 8.70 MYR | 2.61 MYR | -70% |
| IHHHF IHHHF | $1.71 | $1.26 | -26% |
| Tenet Healthcare Corporation THC | $178.75 | $300.86 | +68% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Nakornthon Hospital Public Company (NKT) undervalued?
What is the fair value of NKT?
What is the quality score of NKT?
What is the revenue of Nakornthon Hospital Public Company (NKT)?
What is the net profit margin of NKT?
Does Nakornthon Hospital Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.